Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5761_Библиотеки_им_академика_М_И_Перельмана
.pdf
511
H. Sadeghian, Z. Savand-Roomi, Echocardiographic Atlas of Adult Congenital Heart Disease,
DOI 10.1007/978-3-319-12934-1_157, © Springer International Publishing Switzerland 2015
An 8-year-old girl was referred due to a previous Kawasaki
disease 6 years before.
Diagnosis
The patient was diagnosed with involvement of left main
coronary artery due to Kawasaki disease.
Comment
Regarding the presence of coronary artery involvement,
aspirin was continued [ 160 , 161 ].
Lesson
Some authors believe that dilation of coronary arteries more
than 1.5 times is considered as involvement due to Kawasaki
disease [ 161 ], but indeed it is a defi nition for aneurysm formation due to Kawasaki disease. The size of the coronary
arteries more than 5.5 mm is dilated, and it may be due to
involvement of coronary arteries by Kawasaki disease.
Involvement of Coronary
Artery Due to Kawasaki Disease
Case 157
Fig. 157.1 The left main coronary artery is dilated and irregular (up to
7 mm) in origin in the parasternal short-axis view. AO aorta [ 133 ]
Electronic supplementary material The online version of this
chapter (doi:
10.1007/978-3-319-12934-1_157 ) contains supplementary
material, which is available to authorized users.
513
H. Sadeghian, Z. Savand-Roomi, Echocardiographic Atlas of Adult Congenital Heart Disease,
DOI 10.1007/978-3-319-12934-1, © Springer International Publishing Switzerland 2015
References
1. Mathewson JW, Bichell D, Rothman A, Ing FF. Absent posteroinferior and anterosuperior atrial septal defect rims: factors affecting
nonsurgical closure of large secundum defects using the Amplatzer
occluder. J Am Soc Echocardiogr. 2004;17(1):62–9.
2. Webb GD, Smallhorn JF, Therrien J, Redington AN. Congenital
heart disease. In: Bonow RO, Mann DL, Zipes DP, Libby P,
Breunwald E, editors. Braunwald heart disease, a text book of cardiovascular medicine. 9th ed. Philadelphia: Elsevier Saunders;
2012. p. 1411–67.
3. Sadeghian H, Hajizeinali A, Eslami B, Lotfi -Tokaldany M,
Sheikhfathollahi M, Sahebjam M, et al. Measurement of atrial
septal defect size: a comparative study between transesophageal
echocardiography and balloon occlusive diameter method. J
Tehran Heart Cent. 2010;5(2):74–7.
4. Hajizeinali A, Sadeghian H, Rezvanfard M, Alidoosti M,
Zoroufi an A, Volman MA. A comparison between size of the
occluder device and two-dimensional transesophageal echocardiographic sizing of the ostium secundum atrial septal defect.
Cardiovasc J Afr. 2013;24(5):161–4.
5. O’Byrne ML, Glatz AC, Sunderji S, Mathew AE, Goldberg DJ,
Dori Y, et al. Prevalence of defi cient retro-aortic rim and its effects
on outcomes in device closure of atrial septal defects. Pediatr
Cardiol. 2014;35(7):1181–90.
6. Romanelli G, Harper RW, Mottram PM. Transcatheter closure of
secundum atrial septal defects: results in patients with large and
extreme defects. Heart Lung Circ. 2014;23(2):127–31.
7. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfi eld
JE, Galie N, et al. ESC guidelines for the management of grown up congenital heart disease (new version 2010). Eur Heart
J. 2010;31(23):2915–57 [Practice Guideline].
8. Ofl az MB, Pac FA, Kibar AE, Balli S, Ece I. Evaluation of morphological characteristics of septal rims affecting successful transcatheter atrial septal defect closure in children and adults. Postepy
Kardiol Interwencyjnej. 2013;9(3):205–11.
9. Huang ZW, Fan ZX, Sun JT, Li WM, Gao YQ, Quan YH, et al.
The short- and medium-term results of transcatheter closure of
atrial septal defect with severe pulmonary arterial hypertension.
Heart Vessels. 2012;27(6):603–9 [Case Reports].
10. Skinner GJ, Tulloh RM, Tometzki AJ, Schulze-Neick I, Morgan
GJ. Atrial septal defect closure with an Amplatzer septal occluder
fenestrated with a coronary stent in a child with pulmonary arterial
hypertension. Cardiol Young. 2013;23(5):692–6.
11. Dell’avvocata F, Rigatelli G, Cardaioli P, Giordan M. Home-made
fenestrated amplatzer occluder for atrial septal defect and pulmonary arterial hypertension. J Geriatr Cardiol. 2011;8(2):127–9.
12. Fraisse A, Trivedi KR. Transcatheter closure of atrial septal
defects: how large is too large? Cardiovasc Diagn Ther.
2014;4(3):213–4.
13. Zajarias A, Balzer DT, Lasla J. Percutaneous closure of patent
foramen ovale and atrial septal defect. In: Topol EJ, Teirstein PS,
editors. Text book of interventional cardiology. 6th ed.
Philadelphia: Elsevier Saunders; 2012. p. 603–22.
14. Thanopoulos BD, Dardas P, Ninios V, Eleftherakis N, Karanasios
E. Transcatheter closure of large atrial septal defects with defi cient
aortic or posterior rims using the “Greek maneuver”. A multicenter study. Int J Cardiol. 2013;168(4):3643–6 [Multicenter
Study].
15. Li GS, Li HD, Yang J, Zhang WQ, Hou ZS, Li QC, et al. Feasibility
and safety of transthoracic echocardiography-guided transcatheter
closure of atrial septal defects with defi cient superior-anterior
rims. PLoS One. 2012;7(12):e51117 [Research Support,
Non-U.S. Gov’t].
16. Spence MS, Qureshi SA. Complications of transcatheter closure
of atrial septal defects. Heart. 2005;91(12):1512–4 [Editorial].
17. Pillai AA, Rangaswamy Balasubramanian V, Selvaraj R,
Saktheeswaran M, Satheesh S, Jayaraman B. Utility of balloon
assisted technique in trans catheter closure of very large (>/=35
mm) atrial septal defects. Cardiovasc Diagn Ther. 2014;4(1):
21–7.
18. Schwerzmann M, Windecker S, Meier B. Images in cardiovascular medicine. Swiss cheese-like atrial septal defect. Circulation.
2008;117(24):e490–2.
19. McGarvey J, Ota T, Anderson W, Katz W, Zenati MA. Highly
fenestrated septum primum leads to failure of Amplatzer septal
defect closure. Ann Thorac Surg. 2008;86(3):998–1000 [Case
Reports].
20. Tchana B, Hagler DJ, Carano N, Agnetti A, Squarcia U. Device
closure of fenestrated atrial septal aneurysm: diffi culties and complications with implantation of two devices. J Invasive Cardiol.
2004;16(9):532–4 [Case Reports Review].
21. Cho MJ, Song J, Kim SJ, Choi EY, Lee SY, Shim WS. Transcatheter
closure of multiple atrial septal defects with the Amplatzer device.
Korean Circ J. 2011;41(9):549–51.
22. Prokselj K, Kozelj M, Zadnik V, Podnar T. Echocardiographic
characteristics of secundum-type atrial septal defects in adult
patients: implications for percutaneous closure using Amplatzer
septal occluders. J Am Soc Echocardiogr. 2004;17(11):1167–72.
23. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin 3rd
JP, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the
American College of Cardiology/American Heart Association
Task Force on Practice Guidelines. J Thorac Cardiovasc Surg.
2014;148(1):e1–132.
24. Jung IH, Lee SY, Lee SJ, Lee JY, Park NJ, Ahn DS, et al. Device
closure of a large atrial septal defect in a patient with severe pulmonary arterial hypertension after 1 year use of an oral endothelin
receptor antagonist. J Cardiovasc Ultrasound. 2013;21(3):140–4.
25. Bradley EA, Chakinala M, Billadello JJ. Usefulness of medical
therapy for pulmonary hypertension and delayed atrial septal
defect closure. Am J Cardiol. 2013;112(9):1471–6.
26. Taniguchi Y, Emoto N, Miyagawa K, Nakayama K, Kinutani H,
Tanaka H, et al. Subsequent shunt closure after targeted medical
therapy can be an effective strategy for secundum atrial septal
defect with severe pulmonary arterial hypertension: two case
514
reports: strategy for ASD with severe PAH. Heart Vessels. 2014;
29(2):282–5.
27. Tahara N, Mizoguchi M, Honda A, Tahara A, Nitta Y, Kodama N,
et al. Successful shunt closure and improvement of hemodynamics in an ASD patient with severe pulmonary arterial hypertension
and small shunt following a long-term use of bosentan. Int
J Cardiol. 2012;158(2):e38–40.
28. Park YK, Park JH, Yu JH, Kim JH, Lee JH, Choi SW, et al.
Transient use of oral bosentan can be an additional option to
reduce pulmonary arterial hypertension in a patient with severe
pulmonary arterial hypertension associated with atrial septal
defect. J Cardiovasc Ultrasound. 2011;19(3):159–62.
29. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL,
Barbera JA, et al. Guidelines for the diagnosis and treatment of
pulmonary hypertension. Eur Respir J. 2009;34(6):1219–63
[Guideline].
30. Stuart R. Pulmonary hypertension. In: Bonow RO, Mann DL,
Zipes DP, Libby P, Breunwald E, editors. Braunwald heart disease, a text book of cardiovascular medicine. 9th ed. Philadelphia:
Elsevier Saunders; 2012. p. 1696–718.
31. Therrien J, Rambihar S, Newman B, Siminovitch K, Langleben D,
Webb G, et al. Eisenmenger syndrome and atrial septal defect:
nature or nurture? Can J Cardiol. 2006;22(13):1133–6.
32. Kim SH, Kim KH, Lim YM, Moon JY, Yang WI, Kim IJ, et al.
Delayed embolisation of Amplatzer ASD closure device caused
partial obstruction of left ventricular outfl ow tract. Cardiovasc
J Afr. 2014;25(3):e1–3.
33. Bashir M, Abudhaise H, Mustafa H, Fok M, Bashir A, Hammoud
I, et al. Delayed aorto-right atrial fi stula following percutaneous
closure of atrial septal defect. Ann R Coll Surg Engl. 2014;96(5):
3–4.
34. Feigenbaum H, Armstrong W, Ryan T. Figenbaum’s echocardiography. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
p. 181–213.
35. Otto CM. Text book of clinical echocardiography. 3rd ed.
Philadelphia: Elsevier Saunders; 2004.
36. Vahanian A, Alfi eri O, Andreotti F, Antunes MJ, Baron-Esquivias
G, Baumgartner H, et al. Guidelines on the management of valvular
heart disease (version 2012). Eur Heart J. 2012;33(19):2451–96.
37. Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S,
MacDonald LA, et al. Closure of patent foramen ovale versus
medical therapy after cryptogenic stroke. N Engl J Med. 2013;
368(12):1092–100.
38. Komar M, Podolec P, Przewlocki T, Wilkolek P, TomkiewiczPajak L, Motyl R. Transesophageal echocardiography can help
distinguish between patients with “symptomatic” and “asymptomatic” patent foramen ovale. Kardiol Pol. 2012;70(12):1258–63
[Controlled Clinical Trial].
39. Amin Z. Patent foramen ovale closure. Ann Pediatr Cardiol.
2010;3(1):35–9.
40. Zeinali AMH, Sadeghian H. Interventional closure of patent foramen ovale (PFO) with amplatzer PFO occluder in patients with
paradoxical cerebral embolism. J Tehran Univ Heart Cent.
2006;1(3):167–70.
41. Steiner MM, Di Tullio MR, Rundek T, Gan R, Chen X, Liguori C,
et al. Patent foramen ovale size and embolic brain imaging fi ndings
among patients with ischemic stroke. Stroke. 1998;29(5):944–8.
42. Chen ED, Redberg RF. Echocardiographic evaluation of the
patient with a systemic embolic event. In: Otto CM, editor. The
practice of clinical echocardiography. 3rd ed. Philadelphia:
Saunders; 2007. p. 969–98.
43. Bijl JM, Ruygrok PN, Hornung TS, Wilson NJ, West
T. Percutaneous closure of patent foramen ovale. Intern Med
J. 2005;35(12):706–10 [Evaluation Studies].
44. Nanda NC, Domanski M. Atlas of transesophageal echocardiography. 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 2007.
p. 326–486.
45. Rana BS, Thomas MR, Calvert PA, Monaghan MJ, Hildick-Smith
D. Echocardiographic evaluation of patent foramen ovale prior to
device closure. JACC Cardiovasc Imaging. 2010;3(7):749–60.
46. Rana BS, Shapiro LM, McCarthy KP, Ho SY. Three-dimensional
imaging of the atrial septum and patent foramen ovale anatomy:
defi ning the morphological phenotypes of patent foramen ovale.
Eur J Echocardiogr. 2010;11(10):i19–25.
47. Kerut EK, Norfl eet WT, Plotnick GD, Giles TD. Patent foramen
ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol. 2001;38(3):613–23 [Research
Support, Non-U.S. Gov’t Review].
48. Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr
J. Patent foramen ovale, a possible cause of symptomatic migraine:
a study of 74 patients with acute ischemic stroke. Cerebrovasc
Dis. 2002;13(2):102–6 [Comparative Study].
49. Biasco L, Infantino V, Orzan F, Vicentini S, Rovera C, Longo G,
Chinaglia A, Belli R, Allais G, Gaita F. Impact of transcatheter
closure of patent foramen ovale in the evolution of migraine and
role of residual shunt. J Cardiol. 2014;64(5):390–4.
50. Ailani J. Migraine and patent foramen ovale. Curr Neurol Neurosci
Rep. 2014;14(2):426.
51. Garg P, Servoss SJ, Wu JC, Bajwa ZH, Selim MH, Dineen A, et al. Lack
of association between migraine headache and patent foramen ovale:
results of a case-control study. Circulation. 2010;121(12):1406–12.
52. Cetta F, Minich LL, Maleszewsky JJ, Dearani JA, Burkhart HM.
Atrioventricular septal defect. In: Allen HA, Driscoll DJ, Shaddy
RE, Feltes TF, editors. Moss and Adams’ heart disease in infants,
children, and adolescents. 8th ed. Philadelphia: Lippincott
Williams & Wilkins; 2013. p. 691–712.
53. Yaman ME, Edwards WD, Cetta F. Atrioventricular septal defect.
In: Eidem BJ, Cetta F, O’Leary PW, editors. Echocardiography in
pediatric and adult congenital heart disease. Philadelphia:
Lippincott Williams & Wilkins; 2010. p. 105–15.
54. Seguela PE, Brosset P, Acar PH. Isolated cleft of the posterior
mitral valve leafl et assessed by real-time 3D echocardiography.
Arch Cardiovasc Dis. 2011;104(5):365–6.
55. Furukawa N, Aboud A, Hakim-Meibodi K, Gummert J. Mitral
regurgitation caused by an isolated mitral leafl et cleft. Ann Thorac
Surg. 2011;91(6):1984–6.
56. Edwards WD, Maleszewski JJ. Classifi cation and terminology of
cardiovascular anomalies. In: Allen HA, Driscoll DJ, Shaddy RE,
Feltes TF, editors. Moss and Adams’ Heart disease in infants, children, and adolescents. 8th ed. Philadelphia: Lippincott Williams
& Wilkins; 2013. p. 32–51.
57. Malhotra SP, Lacour-Gayet F, Mitchell MB, Clarke DR, Dines
ML, Campbell DN. Reoperation for left atrioventricular valve
regurgitation after atrioventricular septal defect repair. Ann
Thorac Surg. 2008;86(1):147–51; discussion 51–2.
58. Birim O, van Gameren M, de Jong PL, Witsenburg M, van OschGevers L, Bogers AJ. Outcome after reoperation for atrioventricular septal defect repair. Interact Cardiovasc Thorac Surg. 2009;
9(1):83–7.
59. Prifti E, Bonacchi M, Baboci A, Giunti G, Krakulli K, Vanini
V. Surgical outcome of reoperation due to left atrioventricular
valve regurgitation after previous correction of complete atrioventricular septal defect. J Card Surg. 2013;28(6):756–63.
60. Geva T, Martins JD, Wald RM. Atrial septal defects. Lancet.
2014;383(9932):1921–32 [Review].
61. Sachdeva R. Atrial septal defects. In: Allen HA, Driscoll DJ,
Shaddy RE, Feltes TF, editors. Moss and Adams’ heart disease in
infants, children, and adolescents. 8th ed. Philadelphia: Lippincott
Williams & Wilkins; 2013. p. 672–90.
62. Cho HJ, Chung WJ, Bong JM, Shin KC, Shin MS, Kang WC, Han
HS, Moon C III, Koh KK, Ahn TH, Choi IS, Shin EK. Inferior
sinus venosus type atrial septal defect initially presenting pulmonary hypertension on transthoracic echocardiography. J Cardiovasc
Ultrasound. 2009;17:25–7.
References
515
63. Crystal MA, Al Najashi K, Williams WG, Redington AN,
Anderson RH. Inferior sinus venosus defect: echocardiographic
diagnosis and surgical approach. J Thorac Cardiovasc Surg.
2009;137(6):1349–55.
64. Cetta Jr F, Seward J, O’Leary PW. Echocardiography in congenital heart disease. In: Oh JK, Seward JB, Tajik AJ, editors. The
echo manual. 3rd ed. Rochester: Wolters Kluwer/Lippincott
Williams & Wilkins; 2007. p. 332–67.
65. Cohen GI, White M, Sochowski RA, Klein AL, Bridge PD,
Stewart WJ, et al. Reference values for normal adult transesophageal echocardiographic measurements. J Am Soc Echocardiogr.
1995;8(3):221–30.
66. Raj V, Joshi S, Ho YC, Kilner PJ. Case report: completely
unroofed coronary sinus with a left superior vena cava draining
into the left atrium studied by cardiovascular magnetic resonance.
Indian J Radiol Imaging. 2010;20(3):215–7.
67. Latson LA. Atrial septal defect. In: Moller JH, Hoffman JIE, editors. Pediatric cardiovascular medicine. 1st ed. Philadelphia:
Churchill Livingstone; 2000. p. 311–21.
68. AboulHosn JA, Criley JM, Stringer WW. Partial anomalous pulmonary venous return: case report and review of the literature.
Catheter Cardiovasc Interv. 2003;58(4):548–52 [Case Reports
Review].
69. Sears EH, Aliotta JM, Klinger JR. Partial anomalous pulmonary
venous return presenting with adult-onset pulmonary hypertension. Pulm Circ. 2012;2(2):250.
70. Ammash NM, Seward JB, Warnes CA, Connolly HM, O’Leary
PW, Danielson GK. Partial anomalous pulmonary venous connection: diagnosis by transesophageal echocardiography. J Am Coll
Cardiol. 1997;29(6):1351–8.
71. Brown DW, Geva T. Anomalies of the pulmonary veins. In: Allen
HA, Driscoll DJ, Shaddy RE, Feltes TF, editors. Moss and Adams’
heart disease in infants, children, and adolescents. 8th ed.
Philadelphia: Lippincott Williams & Wilkins; 2013. p. 809–39.
72. Carminati M, Butera G, Chessa M, Drago M, Negura D, Piazza
L. Transcatheter closure of congenital ventricular septal defect with
Amplatzer septal occluders. Am J Cardiol. 2005;96(12):52–8.
73. Carminati M, Butera G, Chessa M, De Giovanni J, Fisher G,
Gewillig M, et al. Transcatheter closure of congenital ventricular
septal defects: results of the European Registry. Eur Heart
J. 2007;28(19):2361–8 [Multicenter Study].
74. Davidson CJ, Bonow R. Cardiac catheterization. In: Bonow RO,
Mann D, Zipes DP, Libby P, Breunwald E, editors. Braunwald’s
heart disease. Philadelphia: Elsevier Saunders; 2012. p. 383–405.
75. Rudolph AM. Ventricular septal defect. Congenital disease of
the heart. 2nd ed. New York: Futura Publishing Company; 2001.
p. 197–244.
76. Gelehrter S, Ensing G. Ventricular septal defects. In: Eidem BW,
Cetta F, O’Leary PW, editors. Echocardiography in pediatric and
adult congenital heart disease. 1st ed. Philadelphia: Lippincott
Williams and Wilkins; 2010. p. 158–75.
77. Fischer G, Apostolopoulou SC, Rammos S, Schneider MB,
Bjornstad PG, Kramer HH. The Amplatzer membranous VSD
occluder and the vulnerability of the atrioventricular conduction
system. Cardiol Young. 2007;17(5):499–504.
78. Zhu D, Lin K, Tang ML, Feng Y, An Q. Midterm results of hybrid
perventricular closure of doubly committed subarterial ventricular
septal defects in pediatric patients. J Card Surg. 2014;29(4):546–53.
79. Devlin PJ, Russell HM, Monge MC, Patel A, Costello JM, Spicer
DE, et al. Doubly committed and juxtaarterial ventricular septal
defect: outcomes of the aortic and pulmonary valves. Ann Thorac
Surg. 2014;97(6):2134–40; discussion 40–1.
80. Holzer RJ, Cheatham JP. Therapeutic cardiac catheterization. In:
Allen HA, Driscoll DJ, Shaddy RE, Feltes TF, editors. Moss and
Adams’ heart disease in infants, children, and adolescents. 8th
ed. Philadelphia: Lippincott Williams & Wilkins; 2013.
p. 288–347.
81. Liu SP, Li L, Yao KC, Wang N, Wang JC. Investigation of membranous ventricular septal defect complicated with tricuspid
regurgitation in ventricular septal defect occlusion. Exp Ther
Med. 2013;5(3):865–9.
82. Webber SA, Sandor GG, Patterson MW. Doppler echocardiographic observations of diastolic trans-septal fl ow through small
ventricular septal defects. Eur Heart J. 1992;13(5):642–5.
83. Suskin N, Rosenberg HC. Diastolic fl ow across a ventricular septal defect: an invitation to a false diagnosis. Can J Cardiol. 1996;
12(4):419–21.
84. Taksande A. Right-sided infective endocarditis with ventricular
septal defect. Pediatr Oncall J. [Letter to editor]. 2013;10(12).
DOI:
10.7199/ped.oncall.2013.56 .
85. Hanada T, Yamauchi M, Sasaki T, Nosaka S, Ku K, Nakayama
K. Tricuspid valve replacement for infectious endocarditis associated with ventricular septal defec-eport of three cases. Nihon
Kyobu Geka Gakkai Zasshi. 1997;45(9):1612–5.
86. Sadeghian H, Karimi A, Ahmadi SH, Lotfi Tokaldany M, Fallah
N, Zavar R, Abbasi SH. Discrete subvalvular aortic stenosis:
severity of aortic regurgitation and rate of recurrence at midterm
follow-up after surgery. J Tehran Univ Heart Cent.
2008;4:219–24.
87. Lopez L. Abnormalities of left ventricular outfl ow. In: Eidem BW,
Cetta F, O’Leary PW, editors. Echocardiography in pediatric and
adult congenital heart disease. Philadelphia: Lippincott Williams
and Wilkins; 2010. p. 215–36.
88. Zielinsky P, Rossi M, Haertel JC, Vitola D, Lucchese FA,
Rodrigues R. Subaortic fi brous ridge and ventricular septal defect:
role of septal malalignment. Circulation. 1987;75(6):1124–9.
89. Cingoz F, Tavlasoglu M, Sahin MA, Kurkluoglu M. Combined
approach in ventricular septal defect and adult pulmonary hypertension. Asian Cardiovasc Thorac Ann. 2013;21(5):596–8.
90. Rudolph AM. Atrial septal defect. Congenital disease of the heart.
New York: Futura Publishing Company; 2001. p. 245–82.
91. Sridhar A, Sahayaraj A, Lakshmi N, Farzana F, Subramanyan R,
Pezzella AT, et al. Cruciate fenestration in ventricular septal
defect patch for high-risk patients with high pulmonary vascular
resistance. World J Pediatr Congenit Heart Surg. 2014;5(3):
494–6.
92. Kamali H, Saritas T, Erdem A, Akdeniz C, Tuzcu V. Percutaneous
closure of large VSD using a home-made fenestrated atrial septal
occluder in 18-year-old with pulmonary hypertension. BMC
Cardiovasc Disord. 2014;14:74.
93. Meijboom F, Szatmari A, Utens E, Deckers JW, Roelandt JR, Bos
E, et al. Long-term follow-up after surgical closure of ventricular
septal defect in infancy and childhood. J Am Coll Cardiol.
1994;24(5):1358–64.
94. Kumar JR, Rajaiah NV, Gupta RB. Large size VSD with pulmonary stenosis. J Assoc Physicians India. 2013;61(12):932–3.
95. Rubio AE, Lewin MB. Ventricular septal defects. In: Allen HA,
Driscoll DJ, Shaddy RE, Feltes TF, editors. Moss and Adams’
heart disease in infants, children, and adolescents. 8th ed.
Philadelphia: Lippincott Williams & Wilkins; 2013. p. 713–21.
96. Pongiglione G, Freedom RM, Cook D, Rowe RD. Mechanism of
acquired right ventricular outfl ow tract obstruction in patients with
ventricular septal defect: an angiocardiographic study. Am
J Cardiol. 1982;50(4):776–80.
97. Silversides CK, Kiess M, Beauchesne L, Bradley T, Connelly M,
Niwa K, et al. Canadian Cardiovascular Society 2009 Consensus
Conference on the management of adults with congenital heart
disease: outfl ow tract obstruction, coarctation of the aorta,
tetralogy of Fallot, Ebstein anomaly and Marfan’s syndrome. Can
J Cardiol. 2010;26(3):e80–97.
98. Hajizeinali A, Sadeghian H, Rezvanfard M, Alidoosti M, Kassaian
SE, Nematipour E. Transcatheter closure of patent ductus arteriosus: initial study on echocardiographic estimation of device size.
J Tehran Heart Cent. 2010;5(4):199–201.
References
516
99. Ramaciotti C, Lemler MS, Moake L, Zellers TM. Comprehensive
assessment of patent ductus arteriosus by echocardiography
before transcatheter closure. J Am Soc Echocardiogr. 2002;15
(10 Pt 2):1154–9 [Comparative Study].
100. Rudolph AM. Functional assessment. Congenital disease of the
heart. New York: Futura Publishing Company; 2001. p. 45–84.
101. Rudolph AM. Prenatal and postnatal pulmonary circulation. In:
Rudolph AM, editor. Congenital diseases of the heart. New York:
Futura Publishing Company; 2001. p. 121–52.
102. Rudolph AM. Pulmonary stenosis and atresia with ventricular
septal defect (Tetralogy of Fallot). In: Rudolph AM, editor.
Congenital disease of the heart. New York: Futura Publishing
Company; 2001. p. 489–549.
103. Roche SL, Greenway SC, Redington AN. Tetralogy of Fallot with
pulmonary stenosis and Tetralogy of Fallot with absent pulmonary
valve. In: Allen HA, Driscoll DJ, Shaddy RE, Feltes TF, editors.
Moss and Adams’ heart disease in infants, children, and adolescents.
8th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.
p. 969–89.
104. Ammash NM, Dearani JA, Burkhart HM, Connolly HM.
Pulmonary regurgitation after tetralogy of Fallot repair: clinical
features, sequelae, and timing of pulmonary valve replacement.
Congenit Heart Dis. 2007;2(6):386–403.
105. Schamberger M, Hurwitz R. Course of right and left ventricular
function in patients with pulmonary insuffi ciency after repair of
tetralogy of Fallot. Pediatr Cardiol. 2000;21(3):244–8.
106. Bonhoeffer P, Boudjemline Y, Saliba Z, Hausse AO, Aggoun Y,
Bonnet D, et al. Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation. 2000;102(7):813–6.
107. Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y,
Bonnet D, et al. Percutaneous replacement of pulmonary valve in
a right-ventricle to pulmonary-artery prosthetic conduit with valve
dysfunction. Lancet. 2000;356(9239):1403–5.
108. Menon S, Cabalka AK. Univentricular atrioventricular connections.
In: Eidem BW, Cetta F, O’leary PW, editors. Echocardiography in
pediatric and adult congenital heart disease. 1st ed. Philadelphia:
Lippincott Williams & Wilkins; 2010. p. 176–95.
109. Wernovsky G. Transposition of the great arteries. In: Allen HA,
Driscoll D, Shaddy RE, Feltes TF, editors. Moss and Adams’ heart
disease in infants, children, and adolescents. Philadelphia:
Lippincott Williams & Wilkins; 2013. p. 1097–146.
110. Rudolph AM. Transposition of the great arteries. In: Rudolph
AM, editor. Congenital disease of the heart. 2nd ed. New York:
Futura Publishing Company; 2001. p. 675–736.
111. Sidi D. Complete transposition of the great arteries. In: Moller JH,
Hoffman JIE, editors. Pediatric cardiovascular medicine. 1st ed.
Philadelphia: Churchill Livingstone; 2000. p. 351–62.
112. Cetta F, Driscoll DJ, Eidem BW. Evaluation of the adult with
transposition after atrial switch operation. In: Eidem BW, Cetta F,
O’Leary PW, editors. Echocardiography in pediatric and adult
congenital heart disease. Philadelphia: Lippincott Williams and
Wilkins; 2010. p. 442–9.
113. Atallah J, Rutledge JM, Dyck JD. Congenitally corrected transposition of the great arteries (atrioventricular and ventriculoarterial
discordance). In: Moss and Adams’ heart disease in infants, children and adolescents. 8th ed. Philadelphia: Lippincott Williams
and Wilkins; 2013. p. 1147–60.
114. Earing MG, Ayres N, Cetta F. Congenitally corrected transposition of the great arteries. In: Eidem BW, Cetta F, O’Leary PW,
editors. Echocardiography in pediatric and adult congenital heart
disease. Philadelphia: Lippincott Williams and Wilkins; 2010.
p. 145–57.
115. Gillis E, Springer R, O’Leary PW. Practical issues related to the
examination, anatomic image orientation, and segmental cardiovascular analysis. In: Eidem BW, Cetta F, O’Leary PW, editors.
Echocardiography in pediatric and adult congenital heart disease.
1st ed. Philadelphia: Lippincott Williams & Wilkins; 2010.
p. 10–28.
116. Prieto LR, Latson LA. Pulmonary stenosis. In: Allen HA, Driscoll
DJ, Shaddy RE, Feltes TF, editors. Moss and Adams’ heart disease in infants, children, and adolescents. 8th ed. Philadelphia:
Lippincott Williams & Wilkins; 2013. p. 913–38.
117. Hallbergson A, Lock JE, Marshall AC. Frequency and risk of instent stenosis following pulmonary artery stenting. Am J Cardiol.
2014;113(3):541–5.
118. Schneider DJ, Moore JW. Aortic stenosis. In: Allen HA, Driscoll
DJ, Shaddy RE, Feltes TF, editors. Moss and Adams’ heart disease in infants, children, and adolescents. 8th ed. Philadelphia:
Lippincott Williams & Wilkins; 2013. p. 1023–43.
119. Neutze JM, Calder AL, Gentles TL, Wilson NJ. Aortic stenosis.
In: Moller JH, Hoffman JIE, editors. Pediatric cardiovascular
medicine. 1st ed. Philadelphia: Churchill Livingstone; 2000.
p. 511–51.
120. Smallhorn J. Echocardiographic assessment of mitral valve abnormalities. In: Eidem BJ, Cetta F, O’Leary PW, editors.
Echocardiography in pediatric and adult congenital heart disease.
Philadelphia: Lippincott Williams and Wilkins; 2010. p. 131–44.
121. Feng TY, Li ZA, He YH, Han JC, Luan SR, Wang LL. Parachute
mitral valve accompanied by bicuspid aortic valve on threedimensional transesophageal echocardiography. Kaohsiung J Med
Sci. 2012;28(9):506–8.
122. Demirkol S, Arslan Z, Balta S, Kucuk U. A parachute mitral valve
accompanying persistent left superior vena cava: assessment by
three-dimensional transthoracic echocardiography. Anadolu
Kardiyol Derg. 2012;12(5):E23–4.
123. Hakim FA, Kendall CB, Alharthi M, Mancina JC, Tajik JA,
Mookadam F. Parachute mitral valve in adults-a systematic overview. Echocardiography. 2010;27(5):581–6.
124. Song MG, Yang HS, Lee DH, Shin JK, Chee HK, Kim JS. Midterm results in patients having tricuspidization of the quadricuspid
aortic valve. J Cardiothorac Surg. 2014;9(1):29.
125. Nikdoust F, Sadeghian H, Eslami B, Majidi S, Javidi D.
Quadricuspid aortic valve diagnosed by transesophageal echocardiography: a case report. J Tehran Heart Cent. 2010;5(2):95.
126. Masuda H, Nakamura T, Mouri N, Sawa Y. Aortic valve replacement for quadricuspid valve: a lesson learnt from a negative experience. Interact Cardiovasc Thorac Surg. 2014;19(2):334–5.
127. Elmistekawy EM1, Malas T, Hynes M, Boodhwani M. Repair of
quadricuspid aortic valve associated with ascending aorta dilatation. J Heart Valve Dis. 2012;21(6):740–2.
128. Aboukhoudir F, Rekik S, Hirsch JL, Aboukhoudir I, Pansieri
M. Large aneurysm of the left sinus of Valsalva in a 54-year-old
man successfully treated with surgery. Ann Cardiol Angeiol
(Paris). 2014;63(5):376–80.
129. Patel N, Rousan TA, Peyton MD, Sivaram CA. Two different presentations of sinus of valsalva aneurysm. Echocardiography.
2014;31(6):E181–4.
130. Cao LB, Hannon D, Movahed A. Noncoronary sinus of Valsalva
rupture into the right atrium with a coexisting perimembranous
ventricular septal defect. World J Clin Cases. 2013;1(4):146–8.
131. Fang ZF, Huang YY, Tang L, Hu XQ, Shen XQ, Tang JJ, et al.
Long-term outcomes of transcatheter closure of ruptured sinus
Valsalva aneurysms using patent ductus arteriosus occluders. Circ
J. 2014;78(9):2197–202.
132. Kassaian SE, Alidoosti M, Sadeghian H, Dehkordi MR.
Transcatheter closure of a coronary fi stula with an Amplatzer
®
vascular plug: should a retrograde approach be standard? Tex
Heart Inst J. 2008;35(1):58.
133. Zhang YQ, Chen SB, Huang GY, Zhang HY, Huang MR, Wang
SS, et al. Coronary artery indexed diameter and z score regression
equations in healthy Chinese Han children. J Clin Ultrasound.
2014;43(1):39–46.
References
517
134. Wailliez A, Wauthy P, Decoodt P, Morissens M. Cor triatriatum in
the adult. Rev Med Brux. 2009;30(3):195–8 [Case Reports].
135. Vikhe VB, Borawake K, Gupta A, Jain J. Cor triatrium presenting as
mitral stenosis and severe anemia. N Am J Med Sci. 2013;5(2):155–6.
136. Abbasi K, Sadeghian H, Ghafari-Marandi N, Sadeghian A. Cor
triatriatum: preoperative diagnosis and successful surgical correction in a four-year-old girl. J Tehran Heart Cent. 2010;5(3):153.
137. Freedom RM, Hashmi A. Total anomalous pulmonary venous
connections and consideration of the Fontan or one-ventricle
repair. Ann Thorac Surg. 1998;66(2):681–2.
138. Cabalka AK, Edwards WD, Dearani JA. Truncus arteriosus. In:
Allen HA, Driscoll DJ, Shaddy RE, Feltes TF, editors. Moss and
Adams’ heart disease in infants, children, and adolescents. 8th ed.
Philadelphia: Lippincott Williams & Wilkins; 2013. p. 990–1002.
139. Webb GJ. Percutaneous therapies for structural heart disease in
adults. In: Bonow RO, Mann D, Zipes DP, Libby P, Breunwald E,
editors. Braunwald heart disease, a text book of cardiovascular medicine. 9th ed. Philadelphia: Elsevier Saunders; 2012. p. 1301–8.
140. Wright GE, Maeda K, Silverman NH, Hanley FL, Roth SJ. Double
outlet right ventricle. In: Allen HA, Driscoll DJ, Shaddy RE,
Feltes TF, editors. Moss and Adams’ heart disease in infants, children, and adolescents. 8th ed. Philadelphia: Lippincott Williams
& Wilkins; 2013. p. 1161–74.
141. Earing MG, Hagler DJ, Edwards WD. Univentricular atrioventricular connection. In: Allen HA, Driscoll DJ, Shaddy RE, Feltes
TF, editors. Moss and Adams’ Heart disease in infants, children,
and adolescents. 8th ed. Philadelphia: Lippincott Williams &
Wilkins; 2013. p. 1175–94.
142. Epstein ML. Tricuspid atresia, stenosis, regurgitation and Uhl’s
anomaly. In: Allen HA, Driscoll D, Shaddy RE, Feltes TF, editors.
Moss and Adams’ heart disease in infants, children, and adolescents. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.
p. 877–88.
143. Sutherland GR, Hatle L, Claus P, Herbots L, Šeparović J. Normal
data. In: Sutherland GR, Hatle L, Claus P, D’hooge J, Bijnens BH,
editors. Doppler myocardial imaging. 1st ed. Belgium: BSWK;
2006. p. 49–102.
144. Attie F, Rosas M, Rijlaarsdam M, Buendia A, Zabal C, Kuri J,
et al. The adult patient with Ebstein anomaly. Outcome in 72
unoperated patients. Medicine (Baltimore). 2000;79(1):27–36.
145. Badano LP, Agricola E, Perez de Isla L, Gianfagna P, Zamorano
JL. Evaluation of the tricuspid valve morphology and function by
transthoracic real-time three-dimensional echocardiography. Eur J
Echocardiogr. 2009;10(4):477–84.
146. Said SM, Dearani JA. In: Allen HA, Driscoll DJ, Shaddy RE,
Feltes TF, editors. Moss and Adams’ heart disease in infants, children, and adolescents. 8th ed. Philadelphia: Lippincott Williams
& Wilkins; 2013. p. 889–913.
147. Celermajer DS, Bull C, Till JA, Cullen S, Vassillikos VP, Sullivan
ID, et al. Ebstein’s anomaly: presentation and outcome from fetus
to adult. J Am Coll Cardiol. 1994;23(1):170–6.
148. Lotfi -Tokaldany M, Majidi S, Nikdoust F, Roomi ZS,
Sheikhfathollahi M, Sadeghian H. Normal values for longitudinal
tissue velocity and strain rate imaging in individual segments of
the left and right ventricles of healthy adult hearts. J Ultrasound
Med. 2013;32(3):463–74.
149. Maclellant-Tobert SG FR. Ebstein anomaly of the tricuspid valve.
In: Moller JH, Hoffman JIE, editors. Pediatric cardiovascular
medicine. 1st ed. Philadelphia: Churchill Livingstone; 2000.
p. 461–8.
150. O’Leary PW. Ebsteins malformation and tricuspid valve disease.
In: Eidem BW, Cetta F, O’Leary PW, editors. Echocardiography
in pediatric and adult congenital heart disease. 1st ed. Philadelphia:
Lippincott Williams & Wilkins; 2010. p. 116–30.
151. Alan LD. Fetal echocardiography. In: Moller JH, Hoffman JIE,
editors. Pediatric cardiovascular medicine. 1st ed. Philadelphia:
Churchill Livingstone; 2000. p. 187–202.
152. Kleinman CS, Glickstein JS, Krishnamurthy G, Votava-Smith JK.
Fetal echocardiography and fetal cardiology. In: Allen HA,
Driscoll DJ, Shaddy RE, Feltes TF, editors. Moss and Adams’
heart disease in infants, children, and adolescents. 8th ed.
Philadelphia: Lippincott Williams & Wilkins; 2013. p. 644–71.
153. Mogra R, Zidere V, Allan LD. Prenatally detectable congenital
heart defects in fetuses with Down syndrome. Ultrasound Obstet
Gynecol. 2011;38(3):320–4.
154. Drose JA. Scanning: indications and technique. In: Drose JA,
editor. Fetal echocardiography. Philadelphia: Saunders; 1998.
p. 15–57.
155. Lehman E. Congenital atresia of the foramen ovale: report of a
case, classifi cation and comment on function. Am J Dis Child.
1927;33:585–9.
156. Szwast A, Natarajan S, Rychik J. Fetal echocardiography. In:
Eidem BW, Cetta F, O’Leary PW, editors. Echocardiography in
pediatric and adult congenital heart disease. 1st ed. Philadelphia:
Lippincott Williams & Wilkins; 2010. p. 477–86.
157. Gurvitz M. General echocardiographic approach to the adult with
suspected congenital heart disease. In: Otto CM, editor. The practice of clinical echocardiography. 3rd ed. Philadelphia: Elsevier
Saunders; 2007. p. 1021–41.
158. Young R, O’Leary PW. Principles of cardiovascular ultrasound.
In: Eidem BW, Cetta F, O’Leary PW, editors. Echocardiography
in pediatric and adult congenital heart disease. 1st ed. Philadelphia:
Lippincott Williams & Wilkins; 2010. p. 1–9.
159. Beekman III RH. Coarctation of the aorta. In: Allen HA, Driscoll
DJ, Shaddy RE, Feltes TF, editors. Moss and Adams’ heart disease in infants, children, and adolescents. 8th ed. Philadelphia:
Lippincott Williams & Wilkins; 2013. p. 1044–60.
160. De Ferranti SD, Newburger JW. Kawasaki disease (mucocutaneous lymph node syndrome). In: Allen HA, Driscoll DJ, Shaddy
RE, Feltes TF, editors. Heart disease in infants, children, and adolescents. 8th ed. Philadelphia: Lippincott Williams & Wilkins;
2013. p. 1287–302.
161. Frommelt MA, Frommelt PC. Vascular abnormalities. In: Eidem
BW, Cetta F, O’Leary PW, editors. Echocardiography in pediatric
and adult congenital heart disease. 1st ed. Philadelphia: Lippincott
Williams & Wilkins; 2010. p. 342–54.
References
Соседние файлы в папке Библиотека им академика М.И. Перельмана